Gerresheimer AG
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a GRRMF research report →
Companywww.gerresheimer.com
Gerresheimer AG, together with its subsidiaries, manufactures and sells packaging products, and drug delivery-devices and solutions worldwide. It operates through Plastics & Devices, Primary Packaging Glass, and Advanced Technologies divisions. The Plastics & Devices division offers drug delivery systems, including inhalers, insulin pen systems, prefillable syringes, and diagnostic systems for the pharma, biotech, diagnostics, and medical technology industries; containers and closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and accessories for solid, liquid, and ophthalmic applications; and bottles and containers for nutritional supplements.
- CEO
- Uwe Ferdinand Röehrhoff
- IPO
- 2009
- Employees
- 13,632
- HQ
- Düsseldorf, DE
Price Chart
Valuation
- Market Cap
- $1.09B
- P/E
- 40.21
- P/S
- 0.42
- P/B
- 0.67
- EV/EBITDA
- 7.86
- Div Yield
- 0.15%
Profitability
- Gross Margin
- 26.89%
- Op Margin
- 7.81%
- Net Margin
- 1.04%
- ROE
- 1.59%
- ROIC
- 2.41%
Growth & Income
- Revenue
- $2.04B · 2.28%
- Net Income
- $109.72M · -5.52%
- EPS
- $3.18 · -8.62%
- Op Income
- $197.47M
- FCF YoY
- -284.31%
Performance & Tape
- 52W High
- $73.80
- 52W Low
- $19.16
- 50D MA
- $23.37
- 200D MA
- $42.70
- Beta
- 0.45
- Avg Volume
- 43
Get TickerSpark's AI analysis on GRRMF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our GRRMF Coverage
We haven't published any research on GRRMF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate GRRMF Report →